Synaptic Ventures is an early-stage venture capital firm specializing in investing in psychedelic medicine. The company focuses on investing in early-stage private companies with the potential to go public, primarily in North American markets. The portfolio includes producers of psychedelic compounds, both natural and synthetic, clinical trial sponsors, and companies developing innovative products in the space. Synaptic Ventures takes an active role in helping its portfolio companies navigate the capital markets in North America. With extensive experience in taking companies public in North America, on the NASDAQ, TSX, and other Canadian exchanges, the firm's team offers valuable expertise to its portfolio companies. Despite the missing information about its founding date, industries, headquarters, last investment, and last investment investors, Synaptic Ventures' commitment to supporting companies in the psychedelic medicine space sets it apart in the venture capital landscape.
General Information
Get notified when Synaptic Ventures moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Synaptic Ventures
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
About Synaptic Ventures
Taxonomy: venture capital, early-stage investing, psychedelic medicine, psychedelic compounds, clinical trials, public markets, capital markets, NASDAQ, TSX, Canadian exchanges, portfolio management, company valuation, business development, strategic partnerships, market access
No funding data available for Synaptic Ventures yet.
Get notified when Synaptic Ventures raises fundingSynaptic Ventures Alternatives & Competitors
Investment Banking services to public and private companies, providing capital raises through our pr...
Close the gap between setting goals and achieving them
Your Capital Markets Team
FAQ About Synaptic Ventures
Don't just browse. Track.
Signal Tracker monitors Synaptic Ventures and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.